# Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma

> **NCT00935844** · PHASE1 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Advanced Solid Tumors
- Lymphoma

## Interventions

- **DRUG:** TAK-901

## Key facts

- **NCT ID:** NCT00935844
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935844, "Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00935844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*